|
⚲
|
| Keyboard |
| Haas Jason
✚
|
|
|---|---|
| CIK # | 0001883821 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001883821] | |
| 4 | [0001883821] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Haas Jason | |
| Ligand Pharmaceuticals Inc | |
| Odyssey Therapeutics Inc | |
| Syros Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2025-06-06 | Grant | 1,209 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2025-06-06 | Grant | 5,783 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-11-18 | Sell | 137,803 | $0.21 | 28,939 |
|
Syros Pharmaceuticals Inc SYRS
Restricted Stock Units · derivative
|
2024-10-31 | Option exercise | 18,875 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-10-31 | Option exercise | 18,875 | ||
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-10-31 | Tax withheld | 5,624 | $2.09 | 11,754 |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-09-12 | Buy | 45,344 | $1.68 | 76,178 |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-09-11 | Buy | 19,293 | $1.58 | 30,483 |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-09-10 | Buy | 35,363 | $1.55 | 54,813 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-06-14 | Grant | 1,252 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2024-06-14 | Grant | 5,444 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-04-01 | Tax withheld | 4,732 | $5.12 | 24,228 |
|
Syros Pharmaceuticals Inc SYRS
Restricted Stock Units · derivative
|
2024-03-31 | Option exercise | 2,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-03-31 | Option exercise | 2,000 | ||
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-03-31 | Option exercise | 13,333 | ||
|
Syros Pharmaceuticals Inc SYRS
Restricted Stock Units · derivative
|
2024-03-31 | Option exercise | 13,333 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2023-11-01 | Tax withheld | 6,301 | $2.22 | 13,988 |
|
Syros Pharmaceuticals Inc SYRS
Restricted Stock Units · derivative
|
2023-10-31 | Option exercise | 18,875 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2023-10-31 | Option exercise | 18,875 | ||
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2023-06-09 | Grant | 5,461 | $0.00 | |
| showing 20 of 32 most recent transactions | |||||